Skip to content

Asset Entities ASST Medical Device — Total revenues

Other segment segments

Asset Management
$1.35M-5.3%
Corporate & Other
$43K

Similar metrics at other companies

Bausch + Lomb logo
BLCODevices — Total revenues
$480M+7.1%
Gentex logo
GNTXMedical Products — Total Revenue
$353.62K-8.6%
Mirion Technologies logo
MIRMedical Segment — Total revenues
$72.1M+5.1%
iRadimed logo
IRMDTotal devices revenue — Total Revenue
$15.39M+18.7%
Agilon Health logo
AGLMedical services revenue — Total revenues
$1.42B-7.3%
Bausch Health Companies logo
BHCProduct sales — Revenue
$2.5B+12.3%

Other financials

Income statement

See full
Revenue$2.8M+1,516%
Operating income-$313.1M-7,588%
Net income-$265.9M-6,993%
EPS (diluted)-$4.53-175%

Balance sheet

See full
Cash & equivalents$95.1M+982%
Total debt$3.4M
Total equity$714.8M+3,548%
Total assets$1.1B+21,931%

Cash flow

See full
Operating cash flow-$31.0M-455%
CapEx--100%
Free cash flow-$31.0M-450%

Valuation

See full
Market cap$1.02B+1,127%
Enterprise value$932M
P/S118.1×

Profitability

See full
Operating margin-6,563%-18,545pp
Net margin-8,022.9%-20,291pp
FCF margin-3,856.7%

Returns & leverage

See full
Return on equity-189.4%+139pp
Debt / equity
Current ratio11.4×+1.7×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Asset Entities's medical device — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Asset Entities's medical device — total revenues?
Asset Entities (ASST) reported medical device — total revenues of $1.37M in Q1 2026.
What does medical device — total revenues mean?
This metric represents the total gross income generated from the sale of products or services within the specific business segment. It serves as a primary indicator of the segment's market demand and top-line growth performance. Tracking this figure helps investors assess the scale and revenue contribution of this business unit relative to the company's overall operations.